Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health

Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes

A randomized trial of 205 pregnant women with gestational diabetes found that adjunctive flash glucose monitoring did not improve time-in-range glucose measurements compared to standard self-monitoring. However, the device was associated with significantly fewer large-for-gestational-age neonates, warranting further investigation in larger studies.
Decoding Glycemic Control in Dialysis: Why HbA1c and Glycated Albumin Require a Nuanced Approach
Posted inDiabetes & Endocrinology Nephrology news

Decoding Glycemic Control in Dialysis: Why HbA1c and Glycated Albumin Require a Nuanced Approach

This study evaluates HbA1c, glycated albumin, and fructosamine against CGM in dialysis patients. While HbA1c and glycated albumin show strong correlations with mean glucose, significant clinical biases from ESA use, BMI, and dialysis modality necessitate cautious, individualized interpretation in clinical practice.
Beyond the Alarm: Does CGM Truly Restore Hypoglycemia Awareness in Older Adults with Type 1 Diabetes?
Posted inDiabetes & Endocrinology Internal Medicine news

Beyond the Alarm: Does CGM Truly Restore Hypoglycemia Awareness in Older Adults with Type 1 Diabetes?

This post hoc analysis of the WISDM study evaluates whether 52 weeks of continuous glucose monitoring (CGM) improves impaired awareness of hypoglycemia (IAH) in older adults. While severe events decreased, physiological awareness remained largely unchanged, revealing critical limitations in current IAH assessment tools.
Short-Term Kanzaki Mulberry Leaf and Water Chestnut Tea Intake Effectively Suppresses Postprandial Blood Glucose Variability: A Randomized Crossover Trial
Posted inDiabetes & Endocrinology news Specialties

Short-Term Kanzaki Mulberry Leaf and Water Chestnut Tea Intake Effectively Suppresses Postprandial Blood Glucose Variability: A Randomized Crossover Trial

A 2-week randomized, double-blind, placebo-controlled crossover trial demonstrated that Kanzaki mulberry leaf and water chestnut tea significantly reduces postprandial glucose variability without adverse safety signals, supporting its potential for glycemic management in healthy adults.